Abstract

Influenza is an acute respiratory illness caused by the influenza A virus, which causes economic losses and social disruption mainly by increasing hospitalization and mortality rates among the elderly and people with chronic diseases. Influenza vaccines are the most effective means of preventing seasonal influenza, but can be completely ineffective if there is an antigenic mismatch between the seasonal vaccine virus and the virus circulating in the community. In addition, influenza viruses resistant to antiviral drugs are emerging worldwide. Thus, there is an urgent need to develop new vaccines and antiviral drugs against these viruses. In this study, we conducted in vitro and in vivo analyses of the antiviral effect of Panax notoginseng root (PNR), which is used as an herbal medicine and nutritional supplement in Korea and China. We confirmed that PNR significantly prevented influenza virus infection in a concentration-dependent manner in mouse macrophages. In addition, PNR pretreatment inhibited viral protein (PB1, PB2, HA, NA, M1, PA, M2, and NP) and viral mRNA (NS1, HA, PB2, PA, NP, M1, and M2) expression. PNR pretreatment also increased the secretion of pro-inflammatory cytokines [tumor necrosis factor alpha and interleukin 6] and interferon (IFN)-beta and the phosphorylation of type-I IFN-related proteins (TANK-binding kinase 1, STAT1, and IRF3) in vitro. In mice exposed to the influenza A H1N1 virus, PNR treatment decreased mortality by 90% and prevented weight loss (by approximately 10%) compared with the findings in untreated animals. In addition, splenocytes from PNR-administered mice displayed significantly enhanced natural killer (NK) cell activity against YAC-1 cells. Taking these findings together, PNR stimulates an antiviral response in murine macrophages and mice that protects against viral infection, which may be attributable to its ability to stimulate NK cell activity. Further investigations are needed to reveal the molecular mechanisms underlying the protective effects of PNR and its components against influenza virus A infection.

Highlights

  • Influenza, an acute viral respiratory illness caused by the influenza virus, is highly contagious and causes global epidemics every year [1,2,3]

  • To determine the optimal concentration of Panax notoginseng root (PNR) that produced antiviral activity with minimal cytotoxicity, we investigated the cytotoxicity of PNR using the trypan blue analysis after treating Madin–Darby canine kidney (MDCK), RAW 264.7, and YAC-1 cells with PNR for 24 h

  • These results show that pro-inflammatory cytokines (IL-6 and tumor necrosis factor (TNF)-α) and IFN-β can be induced by PNR, which can mediate the antiviral status in murine microphage cells

Read more

Summary

Introduction

An acute viral respiratory illness caused by the influenza virus, is highly contagious and causes global epidemics every year [1,2,3]. Approximately one billion people contract influenza each year, and the disease is estimated to cause approximately 300,000–500,000 deaths annually [7, 8]. Vaccines and antiviral agents are mainly used to suppress influenza infection [9]. For seasonal influenza caused by antigenic drift, developing effective vaccines is possible to some extent. It is difficult to predict when outbreaks of new influenza viruses caused by antigenic shift will occur. Influenza vaccines have recently become ineffective for controlling new infections [10]. Antiviral agents have an important role in disease control together with vaccines, as they can prevent further spread of disease and treat currently infected patients [11]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call